Active	Status	Sponsor type	Region	Phase	Filter
4 Active 0 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Zou, Deming
NCT05855395: The Standard of Care Combined With Glucocorticoid in Elderly People With Mild or Moderate COVID-19	Recruiting	N/A	5815	RoW	Glucocorticoid, dexamethasone, prednisone, methylprednisolone	Huashan Hospital	COVID-19	05/24	12/24
He, Fei
CCCG-I/HR-ALL, NCT06764238: Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL Protocol	Not yet recruiting	2/3	1800	RoW	Blinatumomab (Group A), high-dose methotrexate, Venetoclax (nonRand Group), cyclophosphamide, vincristine, dexamethasone, Blinatumomab (Group B)	Institute of Hematology & Blood Diseases Hospital, China	Acute Lymphoblastic Leukemia ALL, Childhood Leukemia, Acute Lymphoblastic, B Cell Acute Lymphoblastic Leukemia (B-ALL)	12/29	06/31
NCT05593575: Efficacy and Safety of SPH3127 Tablets on Treating the Diabetic Kidney Disease	Recruiting	2	320	RoW	SPH3127+SPH3127matching placebo+valsartan matching placebo, SPH3127+valsartan matching placebo, SPH3127 matching placebo+valsartan	Shanghai Pharmaceuticals Holding Co., Ltd	Diabetic Kidney Disease	06/25	06/25
NCT05855395: The Standard of Care Combined With Glucocorticoid in Elderly People With Mild or Moderate COVID-19	Recruiting	N/A	5815	RoW	Glucocorticoid, dexamethasone, prednisone, methylprednisolone	Huashan Hospital	COVID-19	05/24	12/24